JVIM 2024 Flashcards
(322 cards)
A Dose Titration Protocol for Once-Daily Insulin Glargine 300U/mL for the Treatment of Diabetes Mellitus in Dogs
The starting dose of insulin glargine 300 U/mL (IGla300) was 0.5 U/kg once daily in newly diagnosed dogs and a median of 0.8 U/kg (range 0.2–2.5) once daily across all dogs. Glycemic control was rated good or excellent in 92% (87/95) of dogs.
Insulin glargine 300 U/mL is a viable option for once-daily insulin therapy in diabetic dogs. However, due to its low potency and wide dose variability, twice-daily dosing or supplemental meal-time injections may be needed in some cases.
Effect of Sodium-Glucose Cotransporter 2 Inhibitor Canaglifozin on Interstitial Glucose Concentration in
In dogs treated with both insulin and canagliflozin, the median interstitial glucose (IG) was significantly lower at 87 mg/dL (range 40–500 mg/dL) compared to 212 mg/dL (range 41–500 mg/dL) in dogs treated with insulin alone (P < .001).
Hypoglycemia occurred more frequently in dogs receiving both treatments (19% of 2869 IG measurements) than in those on insulin alone (4% of 1426 measurements; P < .001).
Canagliflozin may improve glycemic control in diabetic dogs receiving insulin.
Efficacy and Safety of Once Daily Oral Administration of Sodium Glucose Cotransporter-2 Inhibitor Velagliflozin Compared with Twice Daily Insulin Injection in Diabetic Cats
Day 45, treatment success was achieved in 54% (29/54) of velagliflozin-treated cats and 42% (26/62) of Caninsulin-treated cats
By Day 91, improvements were noted in quality of life (81%), polyuria (54%), and polydipsia (61%) in the velagliflozin group.
Glycemic control based on blood glucose (BG) curves showed mean BG <252 mg/dL in 78% (42/54) of velagliflozin-treated cats and 60% (37/62) of Caninsulin-treated cats.
Minimum BG <162 mg/dL occurred in 76% (41/54) vs. 66% (41/62), and serum fructosamine <450 µmol/L was seen in 76% (41/54) vs. 61% (38/62), respectively.
Once-daily oral velagliflozin was noninferior to insulin injections for managing feline diabetes, providing good quality of life and glycemic control with a lower incidence of clinical hypoglycemia.
Clinicopathological Findings, Treatment, and Outcome in 60 Cats with Gastrointestinal Eosinophilic Sclerosing Fibroplasia
The majority of cats in the study were Domestic Shorthairs, with 12% being Domestic Longhairs. Among pedigree breeds, Ragdolls (25%), Exotic Shorthairs (10%), and Persians (8%) were most common.
Clinical signs were weight loss (60%), hyporexia/anorexia (55%), chronic vomiting (37%), lethargy (35%), and chronic diarrhea (27%) being the most frequently observed. Masses were primarily located in the small intestine (32%), stomach (27%), ileocolic junction (15%), colon (10%), lymph nodes (8%), and mesentery (8%), with 15% of cats having multiple masses.
Eosinophilia was found in 50% and hypoalbuminemia in 28% of cats. Surgical removal of the mass was performed in 37% of cases. Nearly all cats (98%) received corticosteroid therapy. There was no significant difference in survival between surgically and medically treated cats, and 88% were still alive at the time of reporting.
Use of Octreotide for the Treatment of Protein-Losing Enteropathy in Dogs: Retrospective Study of 18 Cases
Octreotide was prescribed in 89% (16/18) of protein-losing enteropathy (PLE) cases with suspected or confirmed intestinal lymphangiectasia (IL) that were unresponsive to standard treatments.
Adverse effects occurred in 17% (3/18) of dogs, leading to drug discontinuation in one case. Clinical improvement was observed in 50% (6/12) of dogs.
efficacy remains unproven, it was generally well tolerated at the doses used in this study.
Prognostic Potential of Copper, Zinc, Copper/Zinc Ratio, Cobalamin, and Serum Amyloid A in Cats with Panleukopenia
Cats with feline panleukopenia virus (FPV) that survived had significantly higher serum copper (Cu), serum amyloid A (SAA), and Cu/Zn ratios, and lower zinc and cobalamin levels compared to healthy controls.
Serum Cu, Cu/Zn ratio, cobalamin, and SAA are strong prognostic biomarkers for FPV in cats, with cobalamin and SAA showing the highest predictive accuracy (AUC 0.98, sensitivity 100%, specificity 80%, PPV 90%).
Diagnostic and Predictive Ability of Hyperbilirubinemia Severity in Cats: A Multicenter Retrospective Study
Cats with BO had significantly higher median TBIL (9.69 mg/dL) compared to those without (1.51 mg/dL; P < .01).
A TBIL cut-off of ≥3.86 mg/dL (≥66 μmol/L) best distinguished cats with BO, offering 94.1% sensitivity and 82.4% specificity. Increasing age was also associated with higher odds of BO (OR 1.20 per year)
Clustering Analysis of Lipoprotein Profiles to Identify Subtypes of Hypertriglyceridemia in Miniature Schnauzers
Dogs with primary hypertriglyceridemia (HTG) were spread across four clusters. One cluster, which included dogs with secondary HTG, had the highest intensities of triglyceride-rich lipoprotein (TRL) and low-density lipoprotein (LDL) fractions. Two other clusters showed moderately elevated TRL and low-to-intermediate LDL intensities. A fourth cluster had high LDL and variable TRL levels, consisting of both normotriglyceridemic (NTG) and mild HTG dogs. The remaining two clusters included only NTG dogs with low TRL and low-to-intermediate LDL intensities. Clinical data did not explain the clustering pattern.
Miniature Schnauzers exhibit a wide range of lipoprotein phenotypes that are not reflected by triglyceride levels alone. Lipoprotein profiling may help identify subtypes with differing causes, health implications, and treatment responses.
Serial Monitoring of Pancreatic Lipase Immunoreactivity, C-Reactive Protein, Abdominal Ultrasonography, and Clinical Severity in Dogs with Suspected Pancreatitis
Dogs with a cPLI ≥400 μg/L had higher median CRP (111.9 mg/L), modified canine activity index (MCAI) (10), and owner-reported health score (OH) (4/10) compared to those with cPLI <400 μg/L (CRP 58.0 mg/L, MCAI 6, OH 6/10), though differences were not statistically significant. Ultrasound signs of pancreatitis may reflect a resolving or subclinical condition, rather than active inflammation, especially in the absence of clinical or biochemical abnormalities.
Viscoelastic Coagulation Monitoring Parameters in Cats with Acute Arterial Thromboembolism
Cats with cardiogenic arterial thromboembolism (ATE) had significantly lower viscoelastic coagulation monitoring (VCM) parameters compared to healthy controls.
Cats with cardiogenic ATE exhibit VCM profiles indicative of hypocoagulability compared to healthy cats, suggesting altered clot strength despite their thrombotic state.
Comparison of Timing of Relapse in Dogs with Nonassociative Immune-Mediated Hemolytic Anemia, Thrombocytopenia, or Polyarthritis
Relapse rates at 12 months varied significantly among immune-mediated diseases (P = .02), with IMPA showing the highest rate (35%) compared to IMHA and ITP (both 11%). By 24 months, relapse rates increased to 41% for IMPA, 18% for IMHA, and 23% for ITP. Most IMPA relapses (90%) occurred within the first year, while IMHA and ITP relapses occurred more evenly over time (56% and 50% within the first year, respectively).
Outcomes of Surgically and Conservatively Managed Thoracolumbar and Lumbosacral Intervertebral Disc Herniations in Dogs
The incidence of intervertebral disc herniation (IVDH) in cats was 0.44% (92/20,849). Surgical treatment had success rates of 62% at 6 weeks and 74% at 6 months, while conservative treatment achieved 54% and 65% success at the same time points
Conservative management may be as effective as surgical decompression for treating thoracolumbar or lumbosacral IVDH in cats, particularly when trauma is involved.
Pharmacodynamic Effects of Molidustat on Erythropoiesis in Healthy Cats
Molidustat significantly increased hematocrit (HCT) compared to placebo starting by Day 14 and remained elevated throughout treatment. On Day 14, Group 2 had a mean HCT of 54.4% vs. 40.3% in placebo (P < .001), and Group 3 reached 61.2% (P < .001). HCT exceeded 60% by Day 21 (Group 2) and Day 14 (Group 3), but returned to within the normal range (29%–45%) after Day 56, aligning with placebo levels by Day 70. Red blood cell count and hemoglobin mirrored the HCT changes
Daily molidustat administration induces strong erythropoietic effects in healthy cats.
Thyroid Function Tests During Nonthyroidal Illness Syndrome and Recovery in Acutely Ill Dogs
At admission, 100% of dogs had low total T4 (TT4)
By 2 weeks post-discharge, low values were seen in 4% (TT4), 8%
Thyroid-stimulating hormone (TSH) remained within the reference interval at admission and discharge, but was elevated in 4% at 2 weeks and 12% at 4 weeks.
Non-thyroidal illness syndrome (NTIS) causes transient changes in thyroid function tests during acute illness in dogs. For accurate thyroid evaluation, measuring TT4 at 2–4 weeks post-discharge or fT4 by equilibrium dialysis (ED) during illness is recommended.
Immunoreactivity of Canine, Feline, and Equine D-Dimer with Antibodies to Human D-Dimer
The monoclonal antibody DD44 showed good specificity and sensitivity for canine D-dimer but did not react with feline or equine D-dimer.
The polyclonal antibody D2D recognized D-dimer in dogs, cats, and horses with good specificity and greater sensitivity
The monoclonal antibody DD44 shows promise for developing a canine-specific D-dimer assay.
The Impact of Single-Dose Trazodone Administration on Plasma Endogenous Adrenocorticotropic Hormone and Serum Cortisol Concentrations in Healthy Dogs
There were no significant differences in endogenous ACTH (P = .23) or pre-ACTH cortisol concentrations (P = .40) between treatment groups. However, post-ACTH cortisol (P = .05) and delta cortisol concentrations (P = .04) were significantly lower when dogs were treated with trazodone.
Trazodone may suppress the adrenocortical response to ACTH stimulation in healthy dogs. If this effect extends to dogs with adrenal disease, trazodone use could potentially influence diagnostic accuracy and treatment decisions in these cases.
Use of Molidustat, A Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, in Chronic Kidney Disease-Associated Anemia in Cats
Molidustat-treated cats showed a weekly increase in HCT, with a significant rise from baseline (23.6%) first observed on Day 21 (27.3%; P < .001). On Day 21, mean HCT was significantly higher in the molidustat group compared to controls
Daily oral molidustat may induce a meaningful erythropoietic response in anemic cats with chronic kidney disease (CKD). This HIF-PH inhibitor shows promise as an alternative to recombinant erythropoietin therapies for managing feline anemia.
MicroRNA-126 in Dogs with Immune Complex-Mediated Glomerulonephritis
No significant differences in serum microRNA (miRNA) expression were observed between early and advanced kidney disease.
However, urinary miR-21 and miR-182 levels were significantly elevated in azotemic dogs (1.63x and 1.45x higher, respectively; adjusted P < .05) and showed weak correlations with tubulointerstitial fibrosis
Urinary miR-126 expression was markedly increased in dogs with immune-complex glomerulonephritis (ICGN)—10.5x, 28.9x, and 126.2x higher compared to dogs with glomerulosclerosis (GS), amyloidosis (AMYL), and healthy controls, respectively.
Urinary miR-126 may serve as a non-invasive biomarker to identify dogs with ICGN who could benefit from immunosuppressive therapy, even without biopsy. Urinary miR-21 and miR-182 may serve as indicators of disease severity and renal fibrosis.
Urine Sodium Concentration After Intravenous Furosemide in Dogs with Acute Congestive Heart Failure and Correlation with Treatment Efficacy
Dogs with low urine sodium (uNa <87 mmol/L) had significantly longer mean time to oxygen discontinuation (timeO₂) compared to those with high uNa (24.2 ± 2.6 hours vs. 16.6 ± 1.7 hours; P = .02).
Factors associated with low uNa included prior use of oral loop diuretics, low serum chloride (sCl), and high packed cell volume (PCV). Urine sodium concentration outperformed traditional markers of diuretic response, including weight loss.
Urine sodium concentration after IV furosemide administration is a valuable predictor of oxygen discontinuation time and diuretic response in dogs with acute CHF
Tolerability of Long Term Cannabidiol Supplementation in Healthy Adult Dogs
Dogs receiving 0 and 5 mg/kg of CBD had similar fecal scores, while the 10 mg/kg group showed a higher frequency of soft stools.
Alkaline phosphatase (ALP) activity increased significantly (P < .0001) in both CBD-treated groups, though all other blood parameters remained within reference ranges.
Aortic Annular Plane Systolic Excursion in Cats with Hypertrophic Cardiomyopathy
Aortic annular plane systolic excursion (AAPSE) was significantly lower in cats with hypertrophic cardiomyopathy (HCM) compared to healthy cats (3.9 ± 0.9 mm vs. 4.6 ± 0.9 mm; P < .001), with the lowest values in stage C HCM cats (2.4 ± 0.6 mm; P < .001). An AAPSE cutoff of <2.9 mm effectively distinguished stage C from stage B HCM with 83% sensitivity and 92% specificity.
AAPSE is a simple, reliable echocardiographic measure that may serve as a novel indicator of left ventricular systolic function in cats with HCM, particularly useful for identifying advanced disease.
Association of the FGF4L2 Retrogene with Fibrocartilaginous Embolic Myelopathy in Dogs
FGF4L2 genotype was determined in 89 dogs with fibrocartilaginous embolic myelopathy (FCE).
FCE was overrepresented in non-chondrodystrophic breeds such as Boxers, Great Danes, Yorkshire Terriers, Bernese Mountain Dogs, Miniature Schnauzers, Rottweilers, and Shetland Sheepdogs.
FCE is rare in chondrodystrophic breeds, supporting historical clinical observations. Since FGF4 is involved in vascular development, further anatomical studies comparing vascular structures in chondrodystrophic versus non-chondrodystrophic dogs may help elucidate FCE pathogenesis.
Factors Associated with Thrombotic Disease in Dogs with Renal Proteinuria: A Retrospective of 150 cases
Cavalier King Charles Spaniels were significantly overrepresented in the thromboembolic disease (TD) group (OR = 98.8; P = .02).
TD cases had higher neutrophil counts (11.06 vs. 7.31 ×10⁹/L; P = .02), lower eosinophil counts (0 vs. 0.17 ×10⁹/L; P = .002), and lower serum albumin levels (2.45 vs. 2.83 g/dL; P= .04).
Arterial thrombi (AT) cases had higher albumin than venous thrombi (VT) cases (2.73 vs. 2.17 g/dL; P = .03), and were older than portal thrombi (PT) cases (10.6 vs. 7.0 years; P = .008). VT cases were older (9.1 vs. 7.0 years; P = .008) and had higher cholesterol than PT cases (398 vs. 255 mg/dL; P = .03).
Variation in clinical and laboratory findings across thrombus locations suggests potential differences in underlying pathogenesis between arterial, venous, and portal thrombi.
Clinical and Genomic Features of Listeria monocytogenes – Associated Mesenteric Lymphadenitis in a Cat
Authors: M. Garcia-de la Virgen, I. Lopez-Almela, A.
Two distinct isolates of Listeria monocytogenes were cultured from the affected mesenteric lymph node and characterized using whole genome sequencing.
The findings may have broader implications for both animal and human health, as well as food safety.